Psilocybe

From MicrobeWiki, the student-edited microbiology resource
This student page has not been curated.

1. Classification

a. Higher order taxa

The genus Psilocybe is of the domain Fungi, the phylum Basidiomycota, the class Agaricomycetes, the order Agaricales, and the family Strophariaceae (1).

2. Description and significance

The genus Psilocybe composes the fungi known as “magic mushrooms.” These are psychedelic mushrooms that produce the metabolite psilocybin (2). Members of this genus are distributed worldwide and are able to grow in most biomes. The greatest species diversity is found in the neotropic zone, specifically Mexico, while other important members are found in the forests of Japan and China (2,3). This genus is important because of the increasing use of its hallucinogenic molecule as a recreational psychedelic drug, as well as its potential use in alleviating the symptoms of certain mental illnesses, such as anxiety, depression, and obsessive-compulsive disorder (4,5). How and why these mushrooms make this molecule is unknown, and current research continues to focus on its effects as opposed to its purpose in the fungi.

3. Genome structure

The DNA genome of Psilocybe cubensis has been sequenced, and sequencing libraries have been constructed (6). The genome contains 32 contigs, and has a total length of 46,603,414 base pairs. The GC content of the total genome is 46.09%, and the AT content is 53.91% (7). The noncoding sequence of the genome is 26,985,414 base pairs in length. It has a GC content of 43.24% and an AT content of 56.76% (7). After being annotated using FunAnnotate, the genome was found to contain 13,478 genes (6).

The genera Psilocybe and Panaelous have many similarities in their rRNA sequences (8,9). The ITS-1 region of Psilocybe varies from roughly 295 to 350 base pairs. In comparison, the genus Panaeolus, shows little variation with a range of about 20 base pairs (8).

A common feature among species in the Psilocybe genus is that all the necessary anabolic, transport, and regulatory genes used in metabolite biosynthesis are organized into genes that may have been acquired via horizontal gene transfer. The psilocybin pathway in particular may have been acquired because of the horizontal gene transfer of a gene cluster (10). Horizontal gene transfer of gene clusters also further supports that the Psilocybe genus is closely related to Panaeolus, another fungi genus that has species that also contain the hallucinogen psilocybin (10).

4. Cell structure

Psilocybe mushrooms are gilled mushrooms that are typically small with brown caps (11, 12). They produce basidiospores that have a non-angular shape with two layers detectable through light microscopy (13). Dormant basidiospores have clearly defined pores on their nuclei, a well defined plasma membrane, mitochondria, lipid bodies, and ribosomes. One of the defining features of the genus Psilocybe is the thickness of the basidiospores they produce. However, Psilocybe spores do not have an endoplasmic reticulum (14). When these spores are germinated with a hot water extract of horse dung, the only differences seen are an increase in small vacuoles and electron density in the germ tubes (14).

5. Metabolic processes

Describe important sources of energy, electrons, and carbon (i.e. trophy) for the organism/organisms you are focusing on, as well as important molecules it/they synthesize(s).

6. Ecology

Habitat; symbiosis; contributions to the environment.

7. Pathology

How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms.

8. Current Research

Include information about how this microbe (or related microbes) are currently being studied and for what purpose

9. References

It is required that you add at least five primary research articles (in same format as the sample reference below) that corresponds to the info that you added to this page. [Sample reference] Faller, A., and Schleifer, K. "Modified Oxidase and Benzidine Tests for Separation of Staphylococci from Micrococci". Journal of Clinical Microbiology. 1981. Volume 13. p. 1031-1035.